Successfully navigating the regulatory hoops becomes even more complicated depending on the market in which manufacturers hope to launch their product.
Sandi Schaible and Dr. Sherry Parker, WuXi AppTec Medical Device Testing03.03.22
The study is designed to demonstrate weight loss and quality of life at 12 months after the ESG procedure when compared to lifestyle modifications alone.
New product will be the market’s first and only to enable optimization of all diabetes medications, insulin and non-insulin alike, according to the company.
A non-surgical solution for obesity approved for one year of device treatment, offering patients potentially more durable weight loss and health benefits.